- Home
- SUPN vs HE Comparison
SUPN vs HE Comparison
Compare SUPN & HE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SUPN | HE |
|---|---|---|
| Founded | 2005 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.6B |
| IPO Year | 2010 | 1994 |
Fundamental Metrics
Financial Performance| Metric | SUPN | HE |
|---|---|---|
| Price | $44.42 | $12.93 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 2 |
| Target Price | ★ $61.60 | $13.25 |
| AVG Volume (30 Days) | 535.7K | ★ 1.5M |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 106.32 |
| EPS | N/A | ★ 0.18 |
| Revenue | $392,755,000.00 | ★ $3,086,896,000.00 |
| Revenue This Year | $22.70 | $7.00 |
| Revenue Next Year | $19.14 | $4.06 |
| P/E Ratio | ★ N/A | $72.47 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $31.16 | $10.30 |
| 52 Week High | $59.68 | $17.33 |
Technical Indicators
Market Signals| Indicator | SUPN | HE |
|---|---|---|
| Relative Strength Index (RSI) | 38.79 | 34.36 |
| Support Level | $43.67 | $10.97 |
| Resistance Level | $52.36 | $13.93 |
| Average True Range (ATR) | 1.41 | 0.35 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 41.04 | 0.56 |
Price Performance
Historical ComparisonAbout SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
About HE Hawaiian Electric Industries Inc.
Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.